A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women

Menopause

Volumn 18, Issue 7, 2011, Pages 778-785

  Blümel, Juan E ^a   Chedraui, Peter ^a,b   Baron, German ^a   Belzares, Emma ^a   Bencosme, Ascanio ^a   Calle, Andres ^a   Danckers, Luis ^a   Espinoza, Maria T ^a   Flores, Daniel ^a   Gomez, Gustavo ^a   Hernandez Bueno, Jose A ^a   Izaguirre, Humberto ^a   Leon Leon, Patricia ^a   Lima, Selva ^a   Mezones Holguin, Edward ^a   Monterrosa, Alvaro ^a   Mostajo, Desire ^a   Navarro, Daysi ^a   Ojeda, Eliana ^a   Onatra, William ^a   Royer, Monique ^a   Soto, Edwin ^a   Tserotas, Konstantinos ^a   Vallejo, Soledad ^a   more..

^a Collaborative Group for Research of the Climacteric in Latin America ^*  (United States)

^b Instituto Para la Salud de la Mujer   (Ecuador)

Author keywords

Latin America.; Menopause; Menopause Rating Scale; Prevalence; Vasomotor symptoms

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CLIMACTERIUM; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE; HORMONAL THERAPY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSE; MENTAL DISEASE; MIDDLE AGED; NULLIPARA; POSTMENOPAUSE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SOUTH AND CENTRAL AMERICA; UROGENITAL TRACT DISEASE; VASOMOTOR DISORDER;

ADULT; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; LATIN AMERICA; MENOPAUSE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; TIME FACTORS; VASOMOTOR SYSTEM; WOMEN'S HEALTH;

EID: 79959736788     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318207851d     Document Type: Article

References (65)

1. NIH State of the Science Conference. Statement on management of menopause related symptoms. NIH Consens State Sci Statements 2005; 22:1-38.
2. Greene JG. Constructing a standard climacteric scale. Maturitas 1998; 29:25-31. (Pubitemid 28247565)
3. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2001;(1): CD002978.
4. Crandall CJ, Zheng Y, Crawford SL, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 2009;16:239-246.
5. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008;118:1234-1240.
6. Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation. Menopause 2009;16:860-869.
7. Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008;23: 1507-1513.
8. Chedraui P, Blümel JE, Baron G, et al. Impaired quality of life among middle aged women: a multicentre Latin American study. Maturitas 2008;61:323-329.
9. Green R, Santoro N. Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond) 2009;5:127-133.
10. Blümel JE, Chedraui P, Baron G, et al; for the Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index. Menopause 2009;16: 1139-1148.
11. Brett KM, Chong Y. Hormone Replacement Therapy: Knowledge and Use in the United States. Hyattsville, MD: National Center for Health Statistics, 2001.
12. World Medical Association. Declaration of Helsinki. JAMA 1997;277: 925-926.
13. CEPAL-ECLAC. Statistical Yearbook for Latin America and the Caribbean. Santiago, Chile: United Nations, 2003.
14. CEPAL. Panorama Social de América Latina. Santiago, Chile: CEPAL, 2003:66.
15. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-272. (Pubitemid 34002968)
16. International Menopause Society. Available at: http://www.imsociety.org/ menopause-terminology.php. Accessed July 1, 2010.
17. Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004;2:45.
18. Aedo S, Porcile A, Irribarra C. Calidad de vida relacionada con el climaterio en una población Chilena de mujeres saludables. Rev Chil Obstet Ginecol 2006;71:402-409.
19. Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007;57:271-278. (Pubitemid 46891702)
20. Berlin Center for Epidemiology and health Research: MRS - The menopause rating scale. Available at: http://www.menopause-rating-scale.info/ languages.htm. Accessed January 7, 2010.
21. Berlin Center for Epidemiology and health Research: MRS - The menopause rating scale. Available at: http://www.menopause-rating-scale.info/ documents/Ref-Values-CountrGr.pdf. Accessed January 7, 2010.
22. Berlin Center for Epidemiology and health Research: MRS - The menopause rating scale. Available at: http://www.menopause-rating-scale.info/ documents/MRS-English.pdf. Accessed January 7, 2010.
23. Chedraui P, Aguirre W, Calle A, et al. Risk factors related to the presence and severity of hot flushes in mid-aged Ecuadorian women. Maturitas 2010;65:378-382.
24. Schnatz PF, Serra J, O'Sullivan DM, Sorosky JI. Menopausal symptoms in Hispanic women and the role of socioeconomic factors. Obstet Gynecol Surv 2006;61:187-193. (Pubitemid 43330403)
25. Ojeda E, Monterrosa A, Blümel JE, Escobar-Loópez J, Chedraui P. Severe menopausal symptoms in mid-aged Latin American women can be related to their indigenous ethnic component. Climacteric 2011; 13:157-163.
26. Crandall CJ, Crawford SL, Gold EB. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med 2006;119:S52-S60. (Pubitemid 44292103)
27. Crawford SL. The roles of biologic and nonbiologic factors in cultural differences in vasomotor symptoms measured by surveys. Menopause 2007;14:725-733. (Pubitemid 47051967)
28. Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Björkelund C. A longitudinal study of the treatment of hot flushes. Menopause 2002; 9:156-161.
29. Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 2009;16:453-457.
30. Pérez JA, Garcia FC, Palacios S, Pérez M. Epidemiology of risk factors and symptoms associated with menopause in Spanish women. Maturitas 2009;62:30-36.
31. Daley AJ, Stokes-Lampard HJ, Macarthur C. Exercise to reduce vasomotor and other menopausal symptoms: a review. Maturitas 2009;63: 176-180.
32. Executive summary. Hormone therapy. American College of Obstetricians and Gynecologists Women's Health Care Physicians. Obstet Gynecol 2004;104:1S-4S.
33. North American Menopause Society. Treatment of menopause associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
34. Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause 2010;17:256-261.
35. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358.
36. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356.
37. Smith-DiJulio K, Percival DB, Woods NF, Tao EY, Mitchell ES. Hot flash severity in hormone therapy users/nonusers across the menopausal transition. Maturitas 2007;58:191-200. (Pubitemid 47503635)
38. Santos-Sá D, Pinto-Neto AM, Conde DM, Pedro AO, Oliveira SC, Costa-Paiva L. Factors associated with the intensity of hot flashes in climacteric women. Rev Assoc Med Bras 2006;52:413-418.
39. Lee MS, Kim JH, Park MS, et al. Factors influencing the severity of menopause symptoms in Korean post-menopausal women. J Korean Med Sci 2010;25:758-765.
40. Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med 2006;355:2338-2347. (Pubitemid 44837782)
41. Fentiman IS, Allen D, Wheeler M, Rymer J. The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT. Climacteric 2006;9:135-145.
42. Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptomsi Menopause 2008;15:841-847.
43. Duché L, Ringa V, Melchior M, et al. Hot flushes, common symptoms, and social relations among middle-aged nonmenopausal French women in the GAZEL cohort. Menopause 2006;13:592-599. (Pubitemid 44079529)
44. Blümel JE, Castelo-Branco C, Cancelo MJ, et al. Relationship between psychological complaints and vasomotor symptoms during climacteric. Maturitas 2004;49:205-210. (Pubitemid 39370787)
45. Murphy PJ, Campbell SS. Sex hormones, sleep, and core body temperature in older postmenopausal women. Sleep 2007;30:1788-1794. (Pubitemid 350234757)
46. Rossmanith WG, Ruebberdt W. What causes hot flushesi The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecol Endocrinol 2009;25:303-314.
47. Warren MP. Missed symptoms of menopause. Int J Clin Pract 2007;61: 2041-2050. (Pubitemid 350077404)
48. Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV. Menopausespecific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas 2009; 62:153-159.
49. Reed SD, Ludman EJ, Newton KM, et al. Depressive symptoms and menopausal burden in the midlife. Maturitas 2009;62:306-310.
50. Seritan AL, Iosif AM, Park JH, DeatherageHand D, Sweet RL, Gold EB. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause 2010;17:410-415.
51. Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause 2009;16:728-734.
52. Woods NF, Smith-Dijulio K, Percival DB, Tao EY, Taylor HJ, Mitchell ES. Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. J Womens Health (Larchmt) 2007;16:667-677. (Pubitemid 47093910)
53. Berecki-Gisolf J, Begum N, Dobson AJ. Symptoms reported by women in midlife: menopausal transition or aging? Menopause 2009;16:1021-1029.
54. Benshushan A, Rojansky N, Chaviv M, et al. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric 2009;12:404-409.
55. Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA. Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril 2006;85:1432-1440.
56. Ozdemir S, Celik C, Görkemli H, Kiyici A, Kaya B. Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome. Int J Gynaecol Obstet 2009;106: 57-61.
57. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006;96:1226-1235. (Pubitemid 43967848)
58. Zhang Q, Li F, Yu Y, Yu X, Sheng Q, Zhang X. Differential factors associated with hot flashes in Chinese perimenopausal and postmenopausal women. Maturitas 2009;63:94-98.
59. Bernis C, Reher DS. Environmental contexts of menopause in Spain: comparative results from recent research. Menopause 2007;14:777-787. (Pubitemid 47051973)
60. Castelo-Branco C, Blumel JE, Chedraui P, et al. Age at menopause in Latin America. Menopause 2006;13:706-712. (Pubitemid 44079541)
61. Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA 2010;303: 1159-1166.
62. Gonzales GF, Villena A. Low pulse oxygen saturation in postmenopausal women at high altitude is related to a high serum testosterone/ estradiol ratio. Int J Gynaecol Obstet 2000;71:147-154.
63. Sievert LL, Vidovic M, Horak H, Abel M. Age and symptom experience at menopause in the Selska Valley, Slovenia. Menopause 2004;11: 223-227. (Pubitemid 40353241)
64. Sievert LL, Flanagan EK. Geographical distribution of hot flash frequencies: considering climatic influences. Am J Phys Anthropol 2005; 128:437-443. (Pubitemid 41407416)
65. Cochran CJ, Gallicchio L, Miller SR, Zacur H, Flaws JA. Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol 2008;112:1037-1044.